Of interest and article archive

Here you will find selected articles from our archive.
For historical articles, please see here.

Go back

August 29, 2025

Thor Medical ASA interim results for 1H 2025 – strong operational and commercial progress

August 29, 2025

Thor Medical and Oncoinvent Enter Strategic Thorium-228 Supply Agreement

August 29, 2025

Invitation to presentation of Thor Medical ASA's first half results 2025

August 22, 2025

Invitation to presentation of Thor Medical ASA's 1H 2025 on Friday 29 August at 08:00

August 4, 2025

Thor Medical and AdvanCell expand strategic supply agreement for Thorium-228

August 1, 2025

Thor Medical ASA – Share capital increase in relation to Subsequent Offering is registered

July 4, 2025

Thor Medical ASA: Final results of the Subsequent Offering

July 3, 2025

Thor Medical ASA: The Subscription Period in the Subsequent Offering ends at 16:30 CEST today

June 26, 2025

Thor Medical ASA: Primary insider notification and disclosure of large shareholdings

June 26, 2025

Thor Medical ASA – Share capital increase in relation to the Private Placement and the PrimaryBid Offering is registered

June 26, 2025

Thor Medical ASA: Commencement of the subscription period for the subsequent offering

June 25, 2025

Thor Medical ASA: Registration of national prospectus and launch of subsequent offering

Thor Medical logo

Contact
Thor Medical HQ

Drammensveien 167
NO-0277 Oslo, Norway
Org.no: 994 297 422
MVA

+ 47 974 14 000

(08.00-16.00 CET)

post@thormedical.com

Design and development by

NXT Oslo Reklamebyrå